Discover CME, tools, and guideline-focused education to improve your knowledge - and patient outcomes.
TAR-200 vs Intravesical Chemotherapy After BGC: Phase 3 Sun-RISe-5 in Non–Muscle-Invasive Bladder Cancer
TAR-210 vs Intravesical Chemotherapy in Intermediate-Risk Non–Muscle-Invasive Bladder Cancer With Susceptible FGFR Alterations: MoonRISe-1
Evolving Trends in Germline Genetic Testing for Prostate Cancer
Real-World Sequencing and Survival in Locally Advanced Prostate Cancer
Updates from Apa-RP: Apalutamide and ADT in High-Risk Localized Prostate Cancer
Making the Case for Dual Ang-2/VEGF-A Inhibition: Anatomical Benefits
Jennifer I. Lim, MD, FARVO
Carl Regillo, MD
ATTRv-PN: A Family Affair?
John Berk, MD
Noel Dasgupta, MD, FACC
Shh…Gene-Silencing Therapies for ATTRv-PN
Sami Khella, MD
Marcia Waddington-Cruz, MD, PhD
The Multiple Faces of ATTRv-PN
Heads Up: It Might Be ATTRv Polyneuropathy – A Microlearning Course on Diagnosis and Treatment
ATTRv-PN: A Complicated Disease With a Poor Prognosis
ATTR Amyloidosis: Familial Vs Wild-Type
Making the Case for Dual Ang-2 VEGF-A Inhibition: Durability and Drying
Duchenne Muscular Dystrophy: Differentiating Advances in Treatment
Omer Abdul Hamid, MD
Nancy Kuntz, MD
Migvis Monduy, MD
SunRISe-1: TAR-200 in BCG-Unresponsive High-Risk Bladder Cancer
Advancing the Treatment of ATTRv-PN: What's in the Pipeline?
Raising the Red Flag: What's Your Index of Suspicion for ATTRv-PN?
GPRC5D-Targeted Bispecifics in Relapsed/Refractory Multiple Myeloma: Practical Expert Consensus on a New Target with Unique Adverse Events
Jeffrey V. Matous, MD
Donna Catamero, NP
Ajai Chari, MD
Gastrointestinal and Hematologic TEAEs Related to ADC Therapy in Gynecologic Cancers
Susana Campos, MD, MPH
Risk Reduction and Management Protocols for Gastrointestinal Adverse Events With ADC Therapy in Breast Cancer
Nadia Harbeck, MD, PhD
Optimal Sequencing of ADCs in Endocrine Refractory HR+/HER2- Metastatic Breast Cancer
Javier Cortes, MD, PhD
Komal Jhaveri, MD, FACP
New and Emerging Agents
David Johnson, MD
Inadequate Bowel Prep: The Achilles' Heel of Colorectal Cancer Screening Colonoscopy
Douglas Rex, MD
Aasma Shaukat, MD, MPH
Screening Colonoscopy in 2024 and Beyond
Patient Education: Telling Is Not Teaching and Listening Is Not Learning
Bowel Prep Hesitancy: What's It All About?
Loading...
We’re glad to see you’re enjoying Prova Education… but how about a more personalized experience?
Press cancel to remain on Prova Education. Press the link below or the continue button to keep going.